All posts tagged "DCGI"
-
E-commerce
Amazon, Flipkart among 20 e-tailors given notices for selling drugs without licence
February 13, 2023Amazon and Flipkart Health plus are among the 20 online sellers that have been issued show-cause...
-
Health
Zydus gets DCGI nod for drug to treat anaemia associated with chronic kidney disease
March 7, 2022Zydus Lifesciences on Monday said it has received an approval from the Drug Controller General of...
-
COVID19
DCGI grants approval to single-shot Sputnik Light Covid vaccine for emergency use: Dr Reddy’s
February 7, 2022Dr Reddy’ Laboratories on Monday said the Drugs Controller General of India (DCGI) has granted approval...
-
COVID19
India to become hub for Covid-19 antiviral generic drugs: Fitch
January 7, 2022India will become the largest global hub for Covid-19 antiviral general drug production after the drug...
-
COVID19
Lupin launches Molnulup for COVID-19 treatment
January 7, 2022Drugmaker Lupin on Friday said it has launched antiviral medication Molnupiravir under the brand name Molnulup...
-
Business
Hetero gets DCGI nod to manufacture, market Molnupiravir capsules
December 28, 2021Hyderabad-based pharmaceuticals firm Hetero on Tuesday said it has received permission from the Drug Controller General...
-
COVID19
Hetero gets DCGI nod for using Tocilizumab biosimilar in COVID treatment
September 6, 2021Drug firm Hetero on Monday said it has received emergency use authorisation from Drug Controller General...
-
COVID19
Zydus Cadila seeks nod for emergency use of ‘needle-free’ Covid-19 vaccine
July 1, 2021Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Drug...
-
COVID19
DCGI gives approval to conduct clinical trial of Colchicine on COVID-19 patients
June 12, 2021The Drugs Controller General of India (DCGI) has given the green light to CSIR and Laxai...
-
COVID19
MSN Lab initiates Phase III clinical trial of Molnupiravir capsules for COVID-19 treatment
May 25, 2021Drug firm MSN Laboratories on Tuesday said it is initiating a phase III clinical trial of...